-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 15th, Poinsettia issued an announcement stating that its wholly-owned subsidiary Guangzhou Poinsettia had recently received the Drug Registration Certificate for Bromhexine Hydrochloride Injection approved and issued by the State Drug Administration
According to the approved drug instructions, the company's bromhexine hydrochloride injection is used for patients with chronic bronchitis and other respiratory diseases such as asthma, bronchiectasis, and silicosis who are difficult to cough up when oral administration is difficult
Bromhexine has a strong phlegm dissolving effect
The approved bromhexine hydrochloride injection is declared according to the new registration classification of chemical drugs in China, and it is deemed to have passed the consistency evaluation